PETROS PHARMACEUTICALS INC (PTPI)
US71678J2096 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 13.34M | 9.43M | 23.85M | 17.14M | 2.15M | |||
| Marketable Securities | N/A | N/A | 0.00 | 0.00 | 0.00 | |||
| Receivables | 2.23M | 2.11M | 2.46M | 5.15M | 2.61M | |||
| Inventories | 1.61M | 1.82M | 520.00K | 760.00K | 2.20M | |||
| Other Current Assets | 3.22M | 1.31M | 3.72M | 2.85M | 5.13M | |||
| Total Current Assets | 20.39M | 14.67M | 30.54M | 25.91M | 12.09M | |||
| Non-Current Assets | ||||||||
| PPE Net | 255.22K | 400.00K | 520.00K | 640.00K | 740.00K | |||
| Goodwill | N/A | N/A | N/A | N/A | 0.00 | |||
| Intangibles | 8.97M | 12.24M | 25.29M | 32.16M | 38.81M | |||
| Other Non-Current Assets | 4.18M | 5.11M | 11.03M | 11.14M | 6.73M | |||
| Total Non-Current Assets | 13.41M | 17.75M | 36.85M | 43.94M | 46.28M | |||
| TOTAL ASSETS | 33.80M | 32.42M | 67.39M | 69.85M | 58.37M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 1.16M | 1.09M | 0.00 | 7.18M | 6.68M | |||
| Accrued Expenses | 7.46M | 3.62M | 23.54M | 26.73M | 23.64M | |||
| Accounts Payable | 1.71M | 1.81M | 4.56M | 5.61M | 3.78M | |||
| Other Current Liabilities | 443.99K | 550.00K | 2.88M | 2.38M | 7.01M | |||
| Total Current Liabilities | 10.77M | 7.07M | 30.98M | 41.89M | 41.10M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 6.86M | 8.39M | 0.00 | 0.00 | 7.06M | |||
| Deferred Taxes/Income | N/A | N/A | N/A | N/A | 1.43M | |||
| Other Non-Current Liabilities | 3.69M | 260.00K | 870.00K | 10.49M | 750.00K | |||
| Total Non-Current Liabilities | 10.55M | 8.65M | 870.00K | 10.49M | 9.25M | |||
| TOTAL LIABILITIES | 21.32M | 15.72M | 31.85M | 52.38M | 50.35M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -98.89M | -90.73M | -70.69M | -61.70M | -41.12M | |||
| Additional Paid In Capital | 110.96M | 107.43M | 106.23M | 79.17M | N/A | |||
| Common Shares | 409.28K | 0.00 | 0.00 | 0.00 | 49.14M | |||
| Shares Outstanding | 2.99M | 2.08M | 2.07M | 970.00K | 970.00K | |||
| Tangible Book Value per Share | 1.04 | 2.14 | 4.95 | -15.14 | -52.38 | |||
| Total Shareholders' Equity | 12.48M | 16.70M | 35.54M | 17.47M | 8.02M | |||
| TOTAL LIABILITIES AND EQUITY | 33.80M | 32.42M | 67.39M | 69.85M | 58.37M | |||
| Statistics | ||||||||
| Debt/Equity | 0.55 | 0.50 | N/A | N/A | 0.88 | |||
| Current Ratio | 1.89 | 2.07 | 0.99 | 0.62 | 0.29 | |||
| Return On Assets (ROA) | -40.88% | -61.81% | -13.34% | -29.48% | -55.70% | |||
| Return On Equity (ROE) | -110.69% | -120.00% | -25.30% | -117.86% | -405.36% | |||
All data in USD